TB Today & Tomorrow: Vaccines, Pipeline Progress, and Community Insights
For decades, the development of an effective new tuberculosis vaccine has remained one of the world’s most urgent public health priorities. Today, with promising vaccine candidates advancing through the pipeline, global momentum around new TB vaccines is growing rapidly.
Join Sabin Vaccine Institute for a timely webinar bringing together leaders from the TB and immunization communities to explore the future of TB vaccines. The session will feature new survey findings on vaccine readiness from the Sabin and the STOP TB Partnership, alongside expert perspectives on leading vaccine candidates including M72/AS01E and Mtbvac, and what countries can consider now to prepare for future introduction and equitable access.
Key Takeaways:
- Insights from TB and immunization communities on vaccine readiness and introduction planning
- Updates on the evolving TB vaccine pipeline, including M72/AS01E and Mtbvac
- Key considerations for preparing countries and communities for next-generation TB vaccines
This webinar is supported by an Unrestricted Educational Grant from GSK Global Health to Sabin.